Sarcopenic obesity in patients awaiting liver transplant: Unique challenges for nutritional recommendations  

作　　者：Darya M Herscovici Katherine M Cooper Alessandro Colletta Michelle Rightmyer Alexandra Shingina Lauren D Feld 

机构地区：[1]Department of Medicine,UMass Chan Medical School,Worcester,MA 01655,United States [2]Division of Transplant Nutrition,UMass Chan Medical School,Worcester,MA 01655,United States [3]Department of Medicine,Vanderbilt University Medical Center,Nashville,TN 37215,United States [4]Division of Gastroenterology,UMass Chan Medical School,Worcester,MA 01655,United States

出　　处：《World Journal of Transplantation》2024年第2期40-47,共8页世界移植杂志

摘　　要：Sarcopenic obesity increases the risk of mortality in patients with liver disease awaiting liver transplantation and in the post-transplant period.Nutrition recommendations for individuals with sarcopenia differ from recommendations for patients with obesity or sarcopenic obesity.While these nutrition guidelines have been established in non-cirrhotic patients,established guidelines for liver transplant candidates with sarcopenic obesity are lacking.In this paper,we review existing literature on sarcopenic obesity in patients with chronic liver disease and address opportunities to improve nutritional counseling in patients awaiting liver transplantation.

关 键 词：NUTRITION SARCOPENIA Sarcopenic obesity Liver transplant CIRRHOSIS Chronic liver disease Body composition MYOSTATIN 

分 类 号：R657.3[医药卫生—外科学]